Related Experiment Video

Updated: Aug 22, 2026

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

[Long-term therapy in childhood epilepsy]

E Raffo1

  • 1Service de Médecine Infantile 1, Hôpital d'Enfants, CHU de Nancy, 1 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France. e.raffo@chu-nancy.fr

Revue Neurologique
|August 28, 2004
PubMed

Insights

This review analyzes pediatric epilepsy treatment guidelines from three sources, focusing on new anti-epileptic drugs. Evaluating treatment effectiveness requires considering the cause and type of epilepsy, not just symptom reduction.

Area of Science:

  • Neurology
  • Pediatrics
  • Pharmacology

Context:

  • Analysis of pediatric epilepsy treatment recommendations from three distinct sources.
  • Focus on guidelines published between 1998 and 2004, with emphasis on new anti-epileptic drugs.
  • Inclusion of data from the Agency for Healthcare Research and Quality and the Cochrane Epilepsy Group.

Purpose:

  • To critically evaluate current treatment recommendations for pediatric epilepsy.
  • To assess the available data on new anti-epileptic drug efficacy in children.
  • To highlight the need for a more holistic approach to treatment evaluation.

Summary:

  • The study reviews pediatric epilepsy treatment guidelines, analyzing data primarily on new anti-epileptic drugs.
  • Therapeutic effects are best understood by considering epilepsy etiology and syndrome.
  • Limited research addresses the impact of epilepsy treatment on a child's quality of life.

Impact:

  • Highlights the importance of individualized treatment strategies in pediatric epilepsy.
  • Underscores the need for further research into quality-of-life outcomes for pediatric epilepsy patients.
  • Provides a critical overview for clinicians and researchers in the field of pediatric epilepsy.

More Related Videos

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...